Stage I/II Hodgkin's disease (HD) with bulky mediastinal disease or other risk factors (RF) the Stanford V experience

被引:0
|
作者
Advani, R. H. [1 ]
Hoppe, R. T. [1 ]
Rosenberg, S. A. [1 ]
Horning, S. J. [1 ]
机构
[1] Stanford Univ, Ctr Canc, Stanford, CA 94305 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:27 / 27
页数:1
相关论文
共 50 条
  • [41] Patterns of Failure in Patients with Stage I/II Bulky Mediastinal Hodgkin Lymphoma (HL) Treated with ABVD plus Radiotherapy or the Stanford V Regimen in the Randomized Phase III North American Intergroup Trial: E2496
    Advani, Ranjana
    Hong, Fangxin
    Gordon, Leo I.
    Gascoyne, Randy D.
    Wagner, Henry
    Hoppe, Richard T.
    Fisher, Richard I.
    Bartlett, Nancy L.
    Kahl, Brad S.
    Stiff, Patrick
    Cheson, Bruce D.
    Belch, Andrew R.
    Friedberg, Jonathan W.
    Kassis, Jeannine
    Blum, Kristie A.
    Habermann, Thomas M.
    Tuscano, Joseph
    Horning, Sandra J.
    BLOOD, 2011, 118 (21) : 696 - 697
  • [42] Somatostatin receptor scintigraphy useful in stage I-II Hodgkin's disease:: more extended disease identified
    Lugtenburg, PJ
    Krenning, EP
    Valkema, R
    Oei, HY
    Lamberts, SWJ
    Eijkemans, MJC
    van Putten, WLJ
    Löwenberg, B
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (04) : 936 - 944
  • [43] CLINICAL STAGE-I AND HODGKIN STAGE-II DISEASE - A SPECIFICALLY TAILORED THERAPY ACCORDING TO PROGNOSTIC FACTORS
    CARDE, P
    BURGERS, JMV
    HENRYAMAR, M
    HAYAT, M
    SIZOO, W
    VANDERSCHUEREN, E
    MONCONDUIT, M
    NOORDIJK, EM
    LUSTMANMARECHAL, J
    TANGUY, A
    DEPAUW, B
    COSSET, JM
    CATTAN, A
    SCHNEIDER, M
    THOMAS, J
    MEERWALDT, JH
    SOMERS, R
    TUBIANA, M
    JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (02) : 239 - 252
  • [44] Prognostic factors for subdiaphragmatic involvement in clinical stage I-II supradiaphragmatic Hodgkin's disease: A retrospective analysis of the GHSG
    Rueffer, U
    Sieber, M
    Josting, A
    Breuer, K
    Grotenhermen, FJ
    Bredenfeld, H
    Tesch, H
    Nisters-Backes, H
    Engert, A
    Diehl, V
    ANNALS OF ONCOLOGY, 1999, 10 (11) : 1343 - 1348
  • [45] RADIOTHERAPY OF STAGE-I AND STAGE-II HODGKIN DISEASE WITH INGUINAL PRESENTATION
    LANZILLO, JH
    MOYLAN, DJ
    MOHIUDDIN, M
    KRAMER, S
    RADIOLOGY, 1985, 154 (01) : 213 - 215
  • [46] THE MANAGEMENT OF STAGE-I-II HODGKINS-DISEASE WITH IRRADIATION ALONE OR COMBINED MODALITY THERAPY - THE STANFORD EXPERIENCE
    HOPPE, RT
    COLEMAN, CN
    COX, RS
    ROSENBERG, SA
    KAPLAN, HS
    BLOOD, 1982, 59 (03) : 455 - 465
  • [47] Clinical factors predictive of the probability of upstaging patients with clinical stage (CS) I or II supradiaphragmatic Hodgkin's disease (HD) to pathological stage (PS) III2 or IV by staging laparotomy
    Aragon, G
    Regueiro, CA
    Martin, M
    Millan, I
    Romero, J
    delaTorre, A
    Polo, E
    Sanz, C
    Valcarcel, FJ
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1193 - 1193
  • [48] Early stage Hodgkin's disease (HD) - Defining the role of radiation therapy (RT)
    Hoppe, R. T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 16 - 16
  • [49] Bulky Hodgkin's disease (HD): Interim results of the GOELAMS randomized H90-M protocol
    Colonna, P
    Delwail, V
    Desablens, B
    Francois, S
    Sensebe, L
    Turlure, P
    Casassus, P
    Simon, M
    LePrise, PY
    Ghandour, C
    Fain, O
    LeMevel, A
    Andrieu, JM
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 779 - 779
  • [50] Clinical stage I and II Hodgkin's disease: Long-term results of therapy without laparotomy - Experience at one institution
    Abrahamsen, AF
    Hannisdal, E
    Nome, O
    Holte, H
    Hager, B
    Langholm, R
    Kvaloy, S
    ANNALS OF ONCOLOGY, 1996, 7 (02) : 145 - 150